20-41348724-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022896.3(LPIN3):c.394G>A(p.Val132Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000308 in 1,613,718 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022896.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LPIN3 | NM_022896.3 | c.394G>A | p.Val132Ile | missense_variant | 4/20 | ENST00000373257.8 | NP_075047.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LPIN3 | ENST00000373257.8 | c.394G>A | p.Val132Ile | missense_variant | 4/20 | 5 | NM_022896.3 | ENSP00000362354 | A2 | |
LPIN3 | ENST00000632009.1 | c.394G>A | p.Val132Ile | missense_variant | 4/20 | 1 | ENSP00000487971 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000224 AC: 34AN: 152078Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000240 AC: 60AN: 250228Hom.: 0 AF XY: 0.000236 AC XY: 32AN XY: 135416
GnomAD4 exome AF: 0.000317 AC: 463AN: 1461640Hom.: 0 Cov.: 31 AF XY: 0.000314 AC XY: 228AN XY: 727108
GnomAD4 genome AF: 0.000224 AC: 34AN: 152078Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74266
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 14, 2023 | The c.394G>A (p.V132I) alteration is located in exon 4 (coding exon 3) of the LPIN3 gene. This alteration results from a G to A substitution at nucleotide position 394, causing the valine (V) at amino acid position 132 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at